Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

ADDvance Pharma in Scandinavia AB

Closing information (x1000 SEK)

Closing information 2025/08 2024/08 2023/08
Turnover 20,409 More Arrow 20,879 Less Arrow 20,185
Financial expenses 2 More Arrow 16 Less Arrow 0
Earnings before taxes 3,641 More Arrow 4,556 Less Arrow 4,179
EBITDA 3,304 More Arrow 4,414 Less Arrow 4,014
Total assets 13,523 Less Arrow 12,355 Less Arrow 11,490
Current assets 12,325 Less Arrow 8,695 More Arrow 9,240
Current liabilities 3,606 Less Arrow 2,391 More Arrow 5,235
Equity capital 9,232 More Arrow 9,327 Less Arrow 5,746
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 2 Equal arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2025/08 2024/08 2023/08
Solvency 68.3% More Arrow 75.5% Less Arrow 50.0%
Turnover per employee 10,204 More Arrow 10,440 Less Arrow 10,092
Profit as a percentage of turnover 17.8% More Arrow 21.8% Less Arrow 20.7%
Return on assets (ROA) 26.9% More Arrow 37.0% Less Arrow 36.4%
Current ratio 341.8% More Arrow 363.7% Less Arrow 176.5%
Return on equity (ROE) 39.4% More Arrow 48.8% More Arrow 72.7%
Change turnover -470 More Arrow 694 More Arrow 6,597
Change turnover % -2% More Arrow 3% More Arrow 49%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/08 2024/08 2023/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.